Increased matrix metalloproteinase-9 activity in unstable carotid plaques: A potential role in acute plaque disruption

Stroke

Volumn 31, Issue 1, 2000, Pages 40-47

  Loftus, Ian M ^a   Naylor, A Ross ^a   Goodall, Stephen ^a   Crowther, Matthew ^a   Jones, Louise ^a   Bell, Peter R F ^a   Thompson, Matthew M ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Atherosclerosis; Cardiovascular diseases; Carotid arteries; Metalloproteinases

Indexed keywords

GELATINASE B;

ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE;

EID: 0033982563     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.1.40     Document Type: Article

References (31)

1. Gaunt ME, Brown L, Hartshorne T, Bell PRF, Naylor AR. Unstable carotid plaques: preoperative identification and association with intraoperative embolisation detected by transcranial Doppler. Eur J Vasc Endovasc Surg. 1996;11:78-82.
2. Smith JL, Evans D, Fan L, Gaunt ME, Martin PJ, Bell PRF, Naylor AR. Interpretation of embolic phenomenon during carotid endarterectomy. Stroke. 1995;26:2281-2284.
3. Vine N, Powell JT. Metalloproteinases in degenerative aortic disease. Clin Sci. 1991;81:233-239.
4. Porter K, Loftus IM, Peterson M, Bell PRF, London NJM, Thompson MM. Marimastat inhibits neointimal thickening in a model of human vein graft stenosis. Br J Surg. 1998;85:1373-1377.
5. Zucker S, Mancuso P, DiMassimo B, Lysik RM, Conner C, Wu CL. Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme linked immunoassays versus substrate degradation assays. Clin Exp Metastasis. 1994;12:13-23.
6. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta. 1993;221:91-103.
7. Carr S, Farb A, Pearce WH, Virmani R, Yao ST. Atherosclerotic plaque rupture in symptomatic carotid artery stenosis. J Vasc Surg. 1996;23:755-765.
8. Falk E, Shah P, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657-671.
9. Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinases and cardiovascular disease. Circ Res. 1995;77:863-868.
10. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. Production and localisation of 92-kD gelatinase in abdominal aortic aneurysms. J Clin Invest. 1995; 96:318-326.
11. Denis LJ, Verweij J. Matrix metalloproteinase inhibitors: present achievements and future prospects. Invest New Drugs. 1997;15: 175-185.
12. Kai H, Ikeda H, Yasukawa H, Kai M, Seki Y, Kuwahara F, Ueno T, Sugi K, Imaizumi T. Peripheral blood levels of matrix metalloproteinases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol. 1998;32:368-372.
13. Henney AM, Wakeley PR, Davies MJ, Foster K, Hembrey R, Murphy G, Humphries S. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc Natl Acad Sci U S A. 1991;88:8154-8158.
14. Nikkari ST, O'Brien KD, Ferguson M, Hatsukami T, Welgus HG, Alpers CE, Clowes AW. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 1995;92:1393-1398.
15. Galis ZS, Sukhova GK, Lark MW, Libby P. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest. 1994;94: 2493-2503.
16. Brown DL, Hibbs MS, Kearney M, Loushin C, Isner JM. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation. 1995;91:2125-2131.
17. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes: implications for plaque rupture. Circulation. 1994;90:775-778.
18. Buja LM, Willerson JT. Role of inflammation in coronary plaque disruption. Circulation. 1994;89:503-505.
19. van der Wal AC, Piek JJ, de Boer OJ, Koch KT, Teeling P, van der Loos CM, Becker AE. Recent activation of the plaque immune response in coronary lesions underlying acute coronary syndromes. Heart. 1998;80:14-18.
20. Mann JM, Kaski JC, Pereira WI, Arie S, Ramires JA, Pileggi F. Histological patterns of atherosclerotic plaques in unstable angina patients vary according to clinical presentation. Heart. 1998;80: 19-22.
21. Welgus HG, Campbell EJ, Curry JD, Eisen AZ, Senior RM, Wilhelm SM, Golberg GI. Neutral metalloproteinases produced by human mononuclear phagocytes: enzyme profile, regulation and cellular differentiation. J Clin Invest. 1990;86:1496-1502.
22. Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, Welgus HG, Wickline SA, Parks WC. Matrilysin is expressed by lipid laden macrophages at sites of potential rupture in atherosclerotic lesions and localises to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A. 1996;93: 9748-9753.
23. Sukhova GK, Schonbeck U, Rahkin E, Schoen FJ, Poole AR, Billinghurst RC, Libby P. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable atheromatous plaques. Circulation. 1999; 99:2503-2509.
24. Johnson JL, Jackson CL, Angelini GD, George SJ. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 1998;18: 1707-1715.
25. Li Z, Li L, Zielke R, Cheng L, Xiao R, Crow M, Stetler-Stevenson WG, Froehlich J, Lakatta EG. Increased expression of 72-kD type IV collagenase (MMP2) in human aortic atherosclerotic lesions. Am J Pathol. 1996;148:121-128.
26. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995; 73:209-215.
27. Allaire E, Hasenstab D, Kenagy RD, Starcher B, Clowes MM, Clowes AW. Prevention of aneurysm development and rupture by local over-expression of plasminogen activator inhibitor-1. Circulation. 1998; 98:249-255.
28. Stemme S, Faber S, Holm J, Wiklund O, Witztum JL, Hansson GK. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc Natl Acad Sci U S A. 1995;92: 3893-3897.
29. Muhlestein JB, Anderson JL, Hammond EH, Zhao L, Trehan S, Schwobe EP, Carlquist JF. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 1998;97: 633-636.
30. Riles TS, Imparato AM, Jacobowitz GR, Lamparello PJ, Giangola G, Adelman MA, Landis R, Kempezinski R, Hobson RW II, AbuRahma AF. The cause of perioperative stroke after carotid endarterectomy. J Vasc Surg. 1994;19:206-216.
31. Davies M, Bland J, Hangartner J, Angelini A, Thomas AC. Factors influencing the presence or absence of acute coronary thrombi in sudden ischaemic death. Eur Heart J. 1989;10:203-208.